NO913745L - Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater - Google Patents

Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater

Info

Publication number
NO913745L
NO913745L NO91913745A NO913745A NO913745L NO 913745 L NO913745 L NO 913745L NO 91913745 A NO91913745 A NO 91913745A NO 913745 A NO913745 A NO 913745A NO 913745 L NO913745 L NO 913745L
Authority
NO
Norway
Prior art keywords
benzocsazine
derivatives
preparing
procedure
benzocsazine derivatives
Prior art date
Application number
NO91913745A
Other languages
English (en)
Norwegian (no)
Other versions
NO913745D0 (no
Inventor
Mitsuru Shiraishi
Shohei Hashiguchi
Toshifumi Watanabe
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO913745D0 publication Critical patent/NO913745D0/no
Publication of NO913745L publication Critical patent/NO913745L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/16—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with only hydrogen or carbon atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO91913745A 1990-09-25 1991-09-24 Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater NO913745L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP25647890 1990-09-25
JP41705090 1990-12-28
JP7674291 1991-03-15
JP20423591 1991-08-14

Publications (2)

Publication Number Publication Date
NO913745D0 NO913745D0 (no) 1991-09-24
NO913745L true NO913745L (no) 1992-03-26

Family

ID=27465972

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913745A NO913745L (no) 1990-09-25 1991-09-24 Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater

Country Status (14)

Country Link
US (1) US5270308A (cs)
EP (1) EP0477789A1 (cs)
KR (1) KR920006336A (cs)
CN (1) CN1060467A (cs)
AU (1) AU640820B2 (cs)
CA (1) CA2052145A1 (cs)
CS (1) CS293291A3 (cs)
FI (1) FI914487L (cs)
HU (1) HUT62003A (cs)
IE (1) IE913186A1 (cs)
IL (1) IL99474A0 (cs)
NO (1) NO913745L (cs)
PL (1) PL291823A1 (cs)
PT (1) PT99030A (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0522606B1 (en) * 1991-05-10 1996-04-03 Takeda Chemical Industries, Ltd. Pyridine derivatives, their production and use
EP0655448B1 (en) * 1992-08-17 2000-04-12 Chugai Seiyaku Kabushiki Kaisha Benzopyran and benzoxazine derivatives
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
JP3814742B2 (ja) * 1996-10-18 2006-08-30 イハラケミカル工業株式会社 4−フルオロサリチル酸類
US6265417B1 (en) * 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
US6593335B1 (en) * 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
US6538004B2 (en) * 2000-03-03 2003-03-25 Abbott Laboratories Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
CN1845726A (zh) * 2003-09-04 2006-10-11 波塞东医药公司 用于治疗心脏心律失常的erg通道开放剂
WO2006002470A1 (en) * 2004-06-30 2006-01-12 Monash University Chiral ligands for asymmetric catalysis
US8258131B2 (en) * 2007-08-01 2012-09-04 Mitsubishi Tanabe Pharma Corporation Fused bicyclic compound
US8383706B2 (en) 2009-06-05 2013-02-26 3M Innovative Properties Company Benzoxazine-thiol adducts
US8389758B2 (en) 2009-06-05 2013-03-05 3M Innovative Properties Company Benzoxazine-thiol adducts
HUE034911T2 (hu) 2009-07-27 2018-03-28 Gilead Sciences Inc Fúzionált heterociklusos vegyületek mint ioncsatorna modulátorok
EP2588197B1 (en) 2010-07-02 2014-11-05 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
WO2012154760A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused heterocyclic compounds as sodium channel modulators
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
NO3175985T3 (cs) 2011-07-01 2018-04-28
ITMI20122221A1 (it) * 2012-12-21 2014-06-22 C4T S C A R L Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende
CN109336781A (zh) * 2018-12-12 2019-02-15 湖南海利常德农药化工有限公司 一种水杨腈的纯化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2321496A1 (de) 1973-04-27 1974-11-14 Nii Farmakol Akad Med 2-aminomethyl-4,4-dialkyl-4h-1,3-benzoxazine, deren salze und verfahren zu ihrer herstellung
JPS57130979A (en) 1981-02-09 1982-08-13 Sankyo Co Ltd 4-amino-1,3-benzoxazine derivative and its preparation
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
US4971982A (en) 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
US5021432A (en) 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
DE3840011A1 (de) * 1988-11-26 1990-05-31 Merck Patent Gmbh Benzoxazinderivate
TW224941B (cs) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd

Also Published As

Publication number Publication date
FI914487A0 (fi) 1991-09-24
KR920006336A (ko) 1992-04-27
PT99030A (pt) 1992-09-30
IL99474A0 (en) 1992-08-18
HUT62003A (en) 1993-03-29
EP0477789A1 (en) 1992-04-01
FI914487A7 (fi) 1992-03-26
CN1060467A (zh) 1992-04-22
AU8474891A (en) 1992-04-02
NO913745D0 (no) 1991-09-24
CA2052145A1 (en) 1992-03-26
HU913050D0 (en) 1992-01-28
PL291823A1 (en) 1992-08-24
US5270308A (en) 1993-12-14
CS293291A3 (en) 1992-08-12
FI914487L (fi) 1992-03-26
AU640820B2 (en) 1993-09-02
IE913186A1 (en) 1992-02-25

Similar Documents

Publication Publication Date Title
NO913234L (no) Fremgangsmaate for fremstilling av pyrazolderivater.
NO903656D0 (no) Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner.
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO914250L (no) Fremgangsmaate for fremstilling av piperazinderivater
NO920965L (no) Fremgangsmaate for fremstilling av etylen-alfa-olefinkopolymerer
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO924028L (no) Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater
NO901832D0 (no) Fremgangsmaate for fremstilling av polyketon.
NO914056D0 (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
NO903780D0 (no) Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
FI911080A7 (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
NO901071L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
FI896075A7 (fi) Menetelmä 4,5,6,7-tetrahydrobentsimidatsolijohdosten valmistamiseksi
NO911368D0 (no) Fremgangsmaate for fremstilling av 2-substituerte alkyl-3-karboksy-karbapenemer.
NO885435L (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
NO904822D0 (no) Fremgangsmaate for fremstilling av pyridinderivater.
NO931897D0 (no) Fremgangsmaate for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
NO893713L (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
NO912980D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
NO925007D0 (no) Fremgangsmaate for fremstilling av benzofuranylimidazolderivater
NO911672D0 (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO910607L (no) Fremgangsmaate for fremstilling av 3'-fluornukleosidanaloger.
NO903196L (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.